Isracann Biosciences Inc.
$0.00+0.00%(+$0.00)
TickerSpark Score
49/100
80
Valuation
20
Profitability
60
Growth
56
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ISCNF research report →
52-Week Range0% of range
Low $0.00
Current $0.00
High $0.00
Companywww.isracann.com
Isracann Biosciences Inc. , together with its subsidiaries, cultivates and distributes medical cannabis in Israel. The company also develops cultivation facilities.
- CEO
- Ajay Singh Kaila
- IPO
- 2017
- HQ
- Vancouver, BC, CA
Price Chart
+900.00% · this period
Valuation
- Market Cap
- $1.76K
- P/E
- -0.47
- P/S
- 0.00
- P/B
- 7.55
- EV/EBITDA
- -0.97
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -221.78%
- ROIC
- -0.05%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-4,693,070 · 81.34%
- EPS
- $-0.03 · 82.33%
- Op Income
- $-2,392,224
- FCF YoY
- 58.65%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.19
- Avg Volume
- 40.01K
Get TickerSpark's AI analysis on ISCNF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our ISCNF Coverage
We haven't published any research on ISCNF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ISCNF Report →